LOXO-305, A Next Generation Reversible BTK Inhibitor, for Overcoming Acquired Resistance to Irreversible BTK Inhibitors
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2018）
关键词
BTK,acquired resistance,chronic lymphocytic leukemia,non-Hodgkin lymphoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要